Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study

Schizophrenia Research
V Molina RodríguezF J Rubia Vila

Abstract

There is a well recognized clinical overlap between primary and secondary neuroleptic negative symptoms in schizophrenia, but their cerebral substrates are probably different. The study of these substrates could contribute to a better understanding and management of these syndromes. In the present work, the cerebral perfusion correlates, as an indirect measure of the underlying neuronal function, of negative symptoms and parkinsonism were studied with single-photon emission tomography in a group of treatment-refractory paranoid schizophrenic patients. Perfusion ratios with respect to the homolateral cerebellum were compared with a normal database. Correlation coefficients were calculated between perfusion ratios, negative symptoms and parkinsonism scores on exploratory grounds. As a group, the patients showed a bilateral, but predominantly left-sided, hypofrontality and hypotemporality, as well as an increased perfusion in right basal ganglia. Negative symptoms scores negatively correlated with prefrontal perfusion, while parkinsonism positively correlated with the activity of primary motor and sensory cortex. These findings support the existence of different cerebral substrates for primary and secondary negative symptoms in sc...Continue Reading

References

Sep 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·V PeraltaM J Cuesta
Dec 1, 1992·Archives of General Psychiatry·A WolkinJ Rotrosen
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleR S Frackowiak
May 1, 1992·The American Journal of Psychiatry·N D VolkowF Henn
Apr 1, 1991·The International Journal of Neuroscience·R SandykA E Merriam
Mar 15, 1991·Biological Psychiatry·H A NasrallahJ A Coffman
Nov 1, 1990·The American Journal of Psychiatry·P E BartaL E Tune
Mar 22, 1990·The New England Journal of Medicine·R L SuddathD R Weinberger
Jun 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L E DeLisiM S Buchsbaum
Jun 1, 1988·Archives of General Psychiatry·H SzechtmanJ M Cleghorn
Apr 1, 1989·The American Journal of Psychiatry·R L SuddathD R Weinberger
Nov 1, 1988·Acta Psychiatrica Scandinavica·A VitaC L Cazzullo
May 1, 1986·Annals of Neurology·B S Oken, K H Chiappa
Feb 1, 1987·The American Journal of Psychiatry·N D VolkowF Gomez-Mont
Dec 1, 1987·Acta Psychiatrica Scandinavica·F A WieselS Stone-Elander
Dec 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·B Pakkenberg
Apr 1, 1987·Acta Psychiatrica Scandinavica·T OtaT Noguchi
Feb 1, 1986·Archives of General Psychiatry·N AndreasenJ H Crossett
Jul 1, 1982·Archives of General Psychiatry·D R WeinbergerR J Wyatt
Mar 1, 1982·The American Journal of Psychiatry·N C AndreasenM R Smith
Jun 1, 1982·Acta Psychiatrica Scandinavica·H NybäckT Hindmarsh
Jul 1, 1995·Biological Psychiatry·J R BustilloR W Buchanan
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·D M QuinlanW Glazer
Jan 1, 1995·Schizophrenia Bulletin·P Martin, M Albers
Jun 1, 1995·Biological Psychiatry·M A HammerW G Iacono
Apr 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·K P EbmeierG M Goodwin
Jan 1, 1995·Psychopathology·J SchröderR Niethammer
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·T Lewander
Mar 1, 1993·Biological Psychiatry·A RossiM Casacchia

❮ Previous
Next ❯

Citations

May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Guillaume VaivaMichel Goudemand
Dec 31, 2002·Schizophrenia Research·V MolinaM Desco
Apr 26, 2003·Psychiatry Research·Manuel DescoVicente Molina
Dec 5, 2013·Psychiatry Research·Alvaro DíezVicente Molina
May 16, 2006·Journal of Psychiatric Research·Paolo BrambillaMichele Tansella
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Mar 8, 2016·The Lancet. Psychiatry·Elias MouchlianitisOliver D Howes
Feb 24, 2001·Nuclear Medicine Communications·A YildizB Karayalcin
Jul 28, 2020·The International Journal of Neuropsychopharmacology·Felipe FregniUNKNOWN Neuromodulation Center Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here